Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats
- 14 July 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 377 (1) , 81-87
- https://doi.org/10.1016/s0014-2999(99)00395-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- BTS 67 582 stimulates insulin secretion from perifused rat pancreatic isletsEuropean Journal of Pharmacology, 1997
- Antazoline increases insulin secretion and improves glucose tolerance in rats and dogsEuropean Journal of Pharmacology, 1997
- Role of α2-Adrenoceptors and Imidazoline-Binding Sites in the Control of Insulin SecretionClinical Science, 1993
- Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080British Journal of Pharmacology, 1993
- Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in ratsEuropean Journal of Pharmacology, 1992
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990
- Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonatesDiabetes, 1989
- Intracellular ATP directly blocks K+ channels in pancreatic B-cellsNature, 1984
- A method for quantifying insulin sensitivity in vivo in the anesthetized rat : the euglycemic insulin clamp technique coupled with isotopic measurement of glucose turnoverReproduction Nutrition Développement, 1983